For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Akero Therapeutics Inc’s stock clocked out at $52.96, down -2.87% from its previous closing price of $54.52. In other words, the price has decreased by -$2.87 from its previous closing price. On the day, 1.92 million shares were traded.
Ratios:
To gain a deeper understanding of AKRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.80 and its Current Ratio is at 16.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 06 ’25 when Rolph Timothy sold 25,000 shares for $55.04 per share. The transaction valued at 1,376,000 led to the insider holds 169,721 shares of the business.
Rolph Timothy sold 12,500 shares of AKRO for $668,634 on Jun 05 ’25. The Chief Scientific Officer now owns 169,721 shares after completing the transaction at $53.49 per share. On Jun 02 ’25, another insider, Lamy Patrick, who serves as the Senior VP, Commercial Strategy of the company, sold 4,000 shares for $50.31 each. As a result, the insider received 201,258 and left with 33,492 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $21.02. The 50-Day Moving Average of the stock is 22.64%, while the 200-Day Moving Average is calculated to be 44.19%.
Shares Statistics:
A total of 79.67M shares are outstanding, with a floating share count of 71.69M. Insiders hold about 10.07% of the company’s shares, while institutions hold 101.98% stake in the company.
